Beste apotheek van Nederland

Saad F, Grahl A S, Aversa A et al. Effects of testosterone on
erectile function: implications for the therapy of erectile
dysfunction. BJU Int 2007;99(5):988-992.
Saad F, Hoesl C E, Oettel M et al. Dehydroepiandrosterone
treatment in the aging male - What should the urologist know?.
Eur Urol 2005;48(5):724-733.
Sadock Virginia A. A sexually compulsive male with erectile
dysfunction treated with Viagra: Discussion. Journal of Sex
Education & Therapy 1998;23(4):275-277.
Safarinejad M R. Prevalence and risk factors for erectile
dysfunction in a population-based study in Iran. Int J Impot Res
2003;15(4):246-252.
Sairam K, Kulinskaya E, Boustead G B et al. Prevalence of
undiagnosed prostate cancer in men with erectile dysfunction.
BJU Int 2002;89(3):261-263.
Sak S C, Eardley I. What is the relationship between benign
prostatic hyperplasia and sexual function?. Sexual &
Relationship Therapy 2004;19(4):431-443.
Sakamoto H, Shimada M, Yoshida H. Hemodynamic evaluation
of the penile arterial system in patients with erectile dysfunction
using power doppler imaging. Urology 2002;60(3):480-484.
Saks Bonnie R. A sexually compulsive male with erectile
dysfunction treated with Viagra: Case report. Journal of Sex
Education & Therapy 1998;23(4):271-274.
Salonia A, Barbieri L, Chen J et al. Comparison of the effect of
sildenafil and apomorphine SL on nocturnal erections in healthy
volunteers: a placebo-controlled study. Eur Urol
2005;47(4):524-529.
Salonia A, Maga T, Colombo R et al. A prospective study
comparing paroxetine alone versus paroxetine plus sildenafil in
patients with premature ejaculation. Br J Urol
2002;168(6):2486-2489.
Salonia A, Rigatti P, Montorsi F. Sildenafil in erectile
dysfunction: a critical review. Curr.Med Res Opin.
2003;19(4):241-262.
Salonia Andrea, Briganti Alberto, Montorsi Piero et al. Safety
and tolerability of oral erectile dysfunction treatments in the
elderly. [References]. Drugs and Aging 2005;22(4):323-338.
Samarasinghe Y, Rivas-Toro H. HEART UK 18th annual
medical and scientific meeting: From diabetes to mixed
hyperlipidaemias. British Journal of Cardiology 2004;11(5):364­
365.
Sathe R S, Komisaruk B R, Ladas A K et al. Naltrexone-induced
augmentation of sexual response in men. Arch Med Res
2001;32(3):221-226.
Sato Y, Horita H, Adachi H et al. Effect of oral
administration of prostaglandin E1 on erectile
dysfunction. Br J Urol 1997;80(5):772-775.
Sato Y, Suzuki N, Adachi H et al. Evaluation of the
alleviative action of neurotropin for penile pain
associated with intracavernous injection of
prostaglandin E1 assessed using the visual analogue
scale. Int J Impot Res 1998;10(1):1-3.
Savoca G, Silvestre G, Belgrano E. Intracavernosal
injection therapy and surgical therapy in diabetic
patients with erectile dysfunction. [Review] [26 refs].
Diabetes, Nutrition & Metabolism - Clinical &
Experimental 2002;15(1):53-57.
Scalvini T, Martini P R, Obici L et al. Infertility and
Hypergonadotropic Hypogonadism as First Evidence
of Hereditary Apolipoprotein A-I Amyloidosis. Br J
Urol 2007;
Schiavi Raul C, Schanzer Harry, Sozio Giampaolo et
al. Erectile function and penile blood pressure in
diabetes mellitus. J Sex Marital Ther 1994;20(2):119­
124.
Schimmer A D, Ali V, Stewart A K et al. Male sexual
function after autologous blood or marrow
transplantation. Biology of Blood & Marrow
Transplantation 2001;7(5):279-283.
Scholz M, Strum S. Re: Recovery of spontaneous
erectile function after nerve-sparing radical retropubic
prostatectomy with and without early intracavernous
injections of alprostadil: results of a prospective,
randomized trial.[comment]. Br J Urol
1999;161(6):1914-1915.
Schouman M, Lacroix P, Amer M. Suppression of
prostaglandin E1-induced pain by dilution of the drug
with lidocaine before intracavernous injection. Br J
Urol 1992;148(4):1266
Schrader S, Mills A, Scheperle M et al. Improvement
in sexual functioning and satisfaction in
nonresponders to testosterone gel: clinical
effectiveness in hypogonadal, HIV-positive males.
Clin Cornerstone 2005;7 Suppl 4S26-S31.
Schroder F H, Whelan P, De Reijke T M et al.
Metastatic prostate cancer treated by flutamide versus
cyproterone acetate. Final analysis of the "European
Organization for Research and Treatment of Cancer"
(EORTC) Protocol 30892. Eur Urol 2004;45(4):457­
464.
Schultheiss D, Stief C G. Physiology and
pathophysiology of erection: Consequences for
present medical therapy of erectile dysfunction.
Andrologia 1999;31(SUPPL. 1):59-64.
D-149